At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 264 enrolled
Drug / intervention
Econazole Nitrate Foam 1% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Randomized, Double-Blind, Vehicle Controlled, Parallel Group Comparison Study of the Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Interdigital Tinea Pedis
In Brief
A Phase 3 clinical trial evaluating Econazole Nitrate Foam 1% and Vehicle Foam for Tinea Pedis and Athlete's Foot. Completed, enrolled 264 participants across 7 sites.
Detailed Summary
This is a study of the safety and efficacy of topical Econazole Nitrate Foam 1% and the foam vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTinea Pedis, Athlete's Foot
CountriesUnited States
CollaboratorsAmDerma Pharmaceuticals, LLC
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2011
First PostedMay 2011
Primary CompletionApr 2012
Study CompletionAug 2012
TodayJul 2026
First PostedMay 16, 2011
Enrollment StartMay 1, 2011
Primary CompletionApr 1, 2012
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 15.1 years ago
Interventions
Econazole Nitrate Foam 1%drug
Econazole Nitrate Foam 1% applied once a day for 4 weeks
Vehicle Foamother
Vehicle foam applied once a day for 4 weeks